- Products & Services
- Knowledge Base
"We will now be able to offer many important and sometimes life-changing research opportunities to all MCI patients."— Karri Venn, COO & President of Centricity
TORONTO, ON, April 05, 2023 /24-7PressRelease/ -- Centricity Research, one of the largest consolidated clinical research networks in North America, and MCI Onehealth, a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, are proud to announce a transformational partnership that will increase patient access to international clinical research studies, accelerate enrollment, and improve retention in sponsored clinical trials across Canada.
"MCI physicians understand the importance of having access to new treatments that can optimize patient care for a variety of illnesses," said Karri Venn, COO and President of Centricity Research. Our partnership with MCI allows clinicians and their patients immediate consideration of new treatment options from our large group of pharmaceutical sponsors.
Benefits to patients
"Partnering with MCI gives us the distinct advantage of offering faster recruitment, leading to faster research conclusions, and faster approval of new treatments for people suffering from various diseases and conditions—it's a win / win / win for patients, their doctors, and companies working hard to develop new treatments," added Venn.
Access to technology that matches patients with rare conditions to available studies
MCI's capacity to quickly and cost-efficiently screen, contact, consent, and engage potential participants for clinical research makes the partnership with Centricity an attractive option for Sponsors looking for expediated trial delivery services. In addition to having access to more than 3.2 million patients, MCI also has partnerships with leading edge tech platforms that allow them to identify patients with rare and chronic conditions for study participation through advanced algorithms. Together, Centricity and MCI will not only to enroll more patients on a quicker timeline, but they will also be able to deploy a substantially larger number of clinical studies to meet the needs of pharmaceutical and life science companies who require a large volume of potentially difficult-to-find patients for such trials.
"Through this partnership with Centricity, MCI vastly expands the scope and volume of clinical trials for which we can offer our entire patient population and our large physician network," said Dr. Alexander Dobranowski, founder and CEO of MCI. We will also leverage our clinical insight capabilities and our purpose-built AI- and tech-enabled tools to decrease enrolment times and speed up trial access. MCI patients will benefit from more varied, more relevant and more efficiently facilitated opportunities to participate in clinical research that can bring with it optimized care for themselves and for future generations."
As one of Canada's largest clinic networks of walk-in, family physicians, specialists and other healthcare services, MCI is the healthcare provider of choice for more than a million patients each year. As a health technology leader, MCI nurtures international opportunities to leverage its vast pool of high-quality structured clinical information. MCI's audience for clinical insights continues to grow in Canada and internationally and will further benefit from collaboration with Centricity.
"This strategic collaboration immediately creates value for multiple stakeholders from MCI's clinical insights as a service program, while optimizing care for the patients of today and tomorrow," added Dobranowski.
About Centricity Research
Centricity Research is one of the largest consolidated research networks in North America with over 45 sites and access to 7.8 million patients across the United States and Canada. As a fully centralized Integrated Research Organization (IRO) with over 150 active investigators, Centricity specializes in conducting Phase I-IV clinical research in over 35 therapeutic areas covering inpatient and outpatient, pharmaceutical, biotechnology, and medical device trials. With a clear focus on patient centricity, it is Centricity's goal to revolutionize clinical research in such a way as to make it easier, more accessible, and more convenient for everyone involved. For more information, visit https://www.centricityresearch.com.
About MCI Onehealth
MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada's leading primary care networks with approximately 280 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via mciconnect.ca. MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company's current roadmap.
# # #